Search research articles
Contact Us
Filters
Showing results (71-80 of 179) with videos related to
Page
of 18
Sort By:
Bioorganic & Medicinal Chemistry
|
March 19, 2004
First pharmacophoric hypothesis for T-type calcium channel blockers
Munikumar Reddy Doddareddy, Hee Kyung Jung, Jae Yeol Lee, et al.
Bioorganic & Medicinal Chemistry
|
March 12, 2003
QSAR studies on piperazinylalkylisoxazole analogues selectively acting on dopamine D3 receptor by HQSAR and CoMFA
Mi Young Cha, In Young Lee, Joo Hwan Cha, et al.
Journal of Molecular Modeling
|
April 27, 2010
3D QSAR pharmacophore model based on diverse IKKβ inhibitors
Shanthi Nagarajan, Asif Ahmed, Hyunah Choo, et al.
Chemical Biology & Drug Design
|
April 8, 2015
Tubulin inhibitor identification by bioactive conformation alignment pharmacophore-guided virtual screening
Shanthi Nagarajan, Min Jeong Choi, Yong Seo Cho, et al.
European Journal of Medicinal Chemistry
|
October 15, 2017
Synthesis and evaluation of new pyridyl/pyrazinyl thiourea derivatives: Neuroprotection against amyloid-β-induced toxicity
Jung-Eun Park, Ahmed Elkamhawy, Ahmed H E Hassan, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2010
Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers
Jie Eun Lee, Hun Yeong Koh, Seon Hee Seo, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 9, 2010
Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents
Vani N Devegowda, Jung Hyun Kim, Ki-Cheol Han, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2013
Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers
Jung-Eun Park, Wan Keun Ji, Jae Wan Jang, et al.
European Journal of Medicinal Chemistry
|
August 12, 2018
Pyrazinyl ureas revisited: 1-(3-(Benzyloxy)pyrazin-2-yl)-3-(3,4-dichlorophenyl)urea, a new blocker of Aβ-induced mPTP opening for Alzheimer's disease
Ahmed Elkamhawy, Jung-Eun Park, Ahmed H E Hassan, et al.
Bioorganic & Medicinal Chemistry
|
November 1, 2006
3D pharmacophore based virtual screening of T-type calcium channel blockers
Munikumar Reddy Doddareddy, Hyunah Choo, Yong Seo Cho, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 179) with videos related to
Sort By:
Page
of 18
Bioorganic & Medicinal Chemistry
|
March 19, 2004
First pharmacophoric hypothesis for T-type calcium channel blockers
Munikumar Reddy Doddareddy, Hee Kyung Jung, Jae Yeol Lee, et al.
Bioorganic & Medicinal Chemistry
|
March 12, 2003
QSAR studies on piperazinylalkylisoxazole analogues selectively acting on dopamine D3 receptor by HQSAR and CoMFA
Mi Young Cha, In Young Lee, Joo Hwan Cha, et al.
Journal of Molecular Modeling
|
April 27, 2010
3D QSAR pharmacophore model based on diverse IKKβ inhibitors
Shanthi Nagarajan, Asif Ahmed, Hyunah Choo, et al.
Chemical Biology & Drug Design
|
April 8, 2015
Tubulin inhibitor identification by bioactive conformation alignment pharmacophore-guided virtual screening
Shanthi Nagarajan, Min Jeong Choi, Yong Seo Cho, et al.
European Journal of Medicinal Chemistry
|
October 15, 2017
Synthesis and evaluation of new pyridyl/pyrazinyl thiourea derivatives: Neuroprotection against amyloid-β-induced toxicity
Jung-Eun Park, Ahmed Elkamhawy, Ahmed H E Hassan, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2010
Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers
Jie Eun Lee, Hun Yeong Koh, Seon Hee Seo, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 9, 2010
Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents
Vani N Devegowda, Jung Hyun Kim, Ki-Cheol Han, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2013
Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers
Jung-Eun Park, Wan Keun Ji, Jae Wan Jang, et al.
European Journal of Medicinal Chemistry
|
August 12, 2018
Pyrazinyl ureas revisited: 1-(3-(Benzyloxy)pyrazin-2-yl)-3-(3,4-dichlorophenyl)urea, a new blocker of Aβ-induced mPTP opening for Alzheimer's disease
Ahmed Elkamhawy, Jung-Eun Park, Ahmed H E Hassan, et al.
Bioorganic & Medicinal Chemistry
|
November 1, 2006
3D pharmacophore based virtual screening of T-type calcium channel blockers
Munikumar Reddy Doddareddy, Hyunah Choo, Yong Seo Cho, et al.
Page
of 18